Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,293 | 60,310 | 67,234 | 68,122 | 77,806 |
| Receivables | 15,740 | 17,740 | 19,688 | 19,916 | 22,191 |
| Inventories | 9,719 | 7,995 | 7,214 | 9,557 | 8,498 |
| Other current assets | 4,035 | 4,403 | 4,373 | 1,462 | 18,268 |
| TOTAL | $91,787 | $90,448 | $98,509 | $99,057 | $126,763 |
| Non-Current Assets | |||||
| PPE Net | 269 | 161 | 42 | 53 | 87 |
| Intangibles | 2,177 | 2,213 | 2,276 | 2,366 | 2,454 |
| Other Non-Current Assets | 22,978 | 19,791 | 19,077 | 19,441 | 14,731 |
| TOTAL | $25,424 | $22,165 | $21,395 | $21,860 | $17,272 |
| Total Assets | $117,211 | $112,613 | $119,904 | $120,917 | $144,035 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,571 | 4,627 | 6,662 | 7,878 | 10,190 |
| Accrued Expenses | 14,888 | 13,875 | 16,406 | 16,638 | 12,788 |
| TOTAL | $22,945 | $18,957 | $23,698 | $25,292 | $43,470 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,773 | 4,199 | 4,202 | 3,196 | 5,229 |
| TOTAL | $6,773 | $4,199 | $4,202 | $3,196 | $5,229 |
| Total Liabilities | $29,718 | $23,156 | $27,900 | $28,488 | $48,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,438 | 45,284 | 45,218 | 44,789 | 44,570 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -495,571 | -492,332 | -487,136 | -480,346 | -473,348 |
| Other shareholders' equity | -612 | 1,401 | 2,264 | -36 | 1,047 |
| TOTAL | $87,493 | $89,457 | $92,004 | $92,429 | $95,336 |
| Total Liabilities And Equity | $117,211 | $112,613 | $119,904 | $120,917 | $144,035 |